TECregen
Pre-clinicalDiscovering, Developing and Commercializing first-in-class therapies targeting thymus regeneration
Founded
2018
Focus
Biologics
About
Discovering, Developing and Commercializing first-in-class therapies targeting thymus regeneration
Funding History
2Total raised: $15.2M
Series A$12MNovartis Venture FundMay 15, 2022
Seed$3.2MZurich Cantonal BankSep 15, 2020
Company Info
TypePrivate
Founded2018
LocationGeneva, Switzerland
StagePre-clinical
Contact
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile